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1. Introduction 
Maffucci syndrome is characterized by the presence of multiple enchondromas associated 
with multiple hemangiomas (figure 1). Enchondromas are common benign cartilage tumors 
of bone. They can occur as solitary lesions or as multiple lesions in enchondromatosis 
(Schwartz 1987, Kaplan 1993). When hemangiomata are associated, the condition is known as 
Maffucci syndrome (figure 2). The patients are normal at birth and the syndrome manifests 
during childhood and puberty. The enchondromas affect the extremities and their distribution 
is asymmetrical. The most common sites of enchondromas are the metacarpal bones and 
phalanges of the hands. The feet are less commonly afflicted. Clinical problems caused by 
enchondromas include skeletal deformity and the potential for malignant change to 
osteosarcoma (figure 3). The risk for sarcomatous degeneration of enchondromas, 
hemangiomas, or lymphangiomas is 15-30%. Maffucci syndrome is also associated with a 
higher risk of CNS, pancreatic, and ovarian malignancies (Ono 2012) (figure 4). 
  
Figure 1. Multiple enchondromas 
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Figure 2. Multiple hemangioma on the sole 
 
 
 
 
 
Figure 3. The differences of length and size of the legs are noted. 
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Figure 4. Brain tumor in a patient with Maffucci syndrome 
2. Inheritance 
Most cases of Maffucci syndrome have been sporadic and no specific hereditary form has 
been proven (Hakak and Azouz 1991). 
It occurs in all races, and occurs in both sexes equally. 
3. Cutaneous presentation of Maffucci syndrome 
Multiple hemangiomas are presented as multiple nodules on the skin of the extremities, 
which looks like grapes (figure 2). However, the sites of hamangiomas are reported to be the 
colon and brain (Lee 1999).  Multiple enchondromas present as a subcutaneous nodules fix 
to the underlining bones. Bleeding from the hemangiomas is clinically important and 
difficult to manage. Complete resection is usually impossible.  Compression therapy is 
recommended. 
4. Melecular genetics of Maffucci syndrome 
The responsible genes for Maffucci syndrome have not been found.  However, some studies 
were reported for multiple enchondromatosis. 
In enchondromas and chondrosarcomas, mutations of the PTHR1 gene was reported to be a 
candidate gene, however, subsequent studies could not confirm it (Hopyan 2002, Rozeman 
2004). 
Somatic heterozygous mutations in IDH1 or IDH2 were reported in enchondromas and 
spindle cell hemangiomas (Pansuriya 2011). Ten cases of 13 (77%) with Maffucci syndrome 
carried IDH1 or IDH2 mutations in their tumors.  IDH1 mutations in cartilage tumors were 
associated with hypermethylation and downregulated expression of several genes (Amary 
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2011). Mutations were absent in DNA isolated from the blood, muscle, or saliva of the 
subjects. Therefore, these mutations are believed to be somatic. 
5. Management of Maffucci syndrome 
Management entails careful examination and monitoring for malignant degenerations.  
Surgical interventions can correct or minimize deformities. 
Compression therapy may be useful to control hemangiomas. 
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